Fig 1.tif (111.95 kB)

Comparison of trough plasma nevirapine concentration (μg/ml) during lead-in and steady state period.

figure

posted on 2017-08-21, 17:29 authored by Bindu Parachalil Gopalan, Kayur Mehta, Reena R. D'souza, Niharika Rajnala, Hemanth Kumar A. K., Geetha Ramachandran, Anita Shet

The difference between lead in (week1, 2) and steady state (week4) trough plasma nevirapine concentration (p = 0.034, p = 0.132) were assessed by Wilcoxon signed rank test.

History

Usage metrics

Read the peer-reviewed publication

Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring

PLOS ONE

Categories

Keywords

antiretroviral treatment initiation Median nevirapine concentrations HPLC trough plasma nevirapine levels drug clearance rates age-appropriate threshold nevirapine concentration lead-in period age 9 years Sub-therapeutic nevirapine concentration dose escalation strategy drug monitoring Nevirapine ART initiation HIV pediatric-focused dosing strategies

Licence

Exports